BPG is committed to discovery and dissemination of knowledge
Observational Study
Copyright ©The Author(s) 2025.
World J Hepatol. Dec 27, 2025; 17(12): 113639
Published online Dec 27, 2025. doi: 10.4254/wjh.v17.i12.113639
Figure 1
Figure 1 Comparison chart of the steatotic liver disease group and the non-steatotic liver disease group. A: Distribution of body mass index categories; B: Distribution of genotypes; C: Liver disease severity based on elastography; D: Distribution of aspartate aminotransferase to platelet ratio index categories; E: Distribution of fibrosis-4 index categories; F: Effectiveness of direct-acting antiviral therapy. SLD: Steatotic liver disease; F: Fibrosis; ITT: Intention-to-treat; PP: Per-protocol.